ArticleFrontiers in oncology2025
Global burden of ovarian cancer attributable to high body mass index among women of childbearing age from 1990 to 2021 and projections to 2050: a systematic analysis for the global burden of disease study 2021.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ovarian cancer (OC) remains a lethal gynecologic cancer marked by substantially reduced 5-year survival probabilities. Elevated BMI (≥25 kg/m²) constitutes a progressively recognized OC risk determinant mediated by chronic inflammatory states and metabolic pathway perturbations. Leveraging GBD 2021 repositories, this investigation quantified high BMI-attributable ovarian cancer burden trajectories among reproductive-age women (WCBA, 15-49 years) worldwide. Methods: Leveraging GBD 2021 repositories, we evaluated worldwide OC burden mediated by elevated BMI across women of childbearing age (WCBA) during 1990-2021. Evaluated metrics comprised deaths, DALYs, YLDs, YLLs, and ASR (EAPC-based trend analysis). ARIMA and Exponential Smoothing models generated 2050 burden projections. Results: From 1990 to 2021, the global burden of OC attributable to high BMI increased significantly. In 2021, there were 17,344 deaths (95% UI: 4,141-30,810) and 477,248 DALYs (95% UI: 113,449-840,002) among WCBA. The ASMR rose from 0.32 (95% UI: 0.07-0.61) to 0.38 (95% UI: 0.09-0.67) per 100,000 (EAPC: 1.03, 95% CI: 0.85-1.21). The ASDR increased from 8.72 (95% UI: 1.78-16.41) to 10.56 (95% UI: 2.50-18.57) per 100,000 (EAPC: 1.09, 95% CI: 0.93-1.25). The burden peaked in the 45-49 age group, with 995 deaths and 44,223 DALYs. High SDI regions had the highest ASMR (0.57, 95% UI: 0.14-1.01) and ASDR (15.13, 95% UI: 3.79-26.82). Projections indicate a continued increase in the OC burden attributable to high BMI by 2050, with the ASMR reaching 0.43 (95% HDI: 0.40-0.46) and the ASDR reaching 12.28 (95% HDI: 11.58-12.98). Conclusion: This study highlights the escalating global burden of OC attributable to high BMI among WCBA, particularly in high SDI regions. This investigation delineates progressively intensifying worldwide OC burden mediated by elevated BMI in WCBA, disproportionately affecting high SDI territories.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.